Google Übersetzer
Polaryx Therapeutics, Inc.
About
2.58USD-1.02 -28.33%
Closed • Updated at 13:21 GMT+00:00Market Cap$122.15M
Volume1.23M
Beta-4.27
RSI33.46
Polaryx Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
Apr 21 2026
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
Apr 15 2026
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
Apr 1 2026
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
Mar 17 2026
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Recent Videos
Polaryx Therapeutics - $PLYX - Ep:060 - Nano Cap Podcast
Apr 21, 2026
Novel Therapeutic and Trial Approaches for Lysosomal Storage Disorders with Polaryx’s Alex Yang
Apr 01, 2026
17 March 26. Biotech Stock News. Daily Recap. #English #Shorts $XBI #trading #biotechnews #dailynews
Mar 17, 2026
FRESH BREAKOUT | PLYX STOCK ANALYSIS | POLARYX THERAPEUTICS STOCK
Mar 17, 2026
Community Chat
Ask AI
Try asking